Literature DB >> 18942156

Glucose-6-phosphate dehydrogenase laboratory assay: How, when, and why?

Angelo Minucci1, Bruno Giardina, Cecilia Zuppi, Ettore Capoluongo.   

Abstract

Glucose 6-phosphate dehydrogenase (G6PD) deficiency is the most common defect of red blood cells. Although some different laboratory techniques or methods are employed for the biochemical screening, a strict relationship between biochemists, clinicians, and molecular biologists is necessary for a definitive diagnosis. This article represents an overview on the current laboratory tests finalized to the screening or to the definitive diagnosis of G6PD-deficiency, underlying the problems regarding the biochemical and molecular identification of heterozygote females other than those regarding the standardization of the clinical and laboratory diagnostic procedures. Finally, this review is aimed to give a flow-chart for the complete diagnostic approach of G6PD-deficiency.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18942156     DOI: 10.1002/iub.137

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  37 in total

1.  Knowledge, Attitudes, and Practice Regarding Genetic Testing and Genetic Counselors in Jordan: A Population-Based Survey.

Authors:  Mamoun Ahram; Majd Soubani; Lana Abu Salem; Haneen Saker; Muayyad Ahmad
Journal:  J Genet Couns       Date:  2015-04-08       Impact factor: 2.537

Review 2.  Glucose-6-phosphate dehydrogenase, NADPH, and cell survival.

Authors:  Robert C Stanton
Journal:  IUBMB Life       Date:  2012-03-20       Impact factor: 3.885

3.  Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.

Authors:  Thomas Bontant; Sophie Le Garrec; David Avran; Stephane Dauger
Journal:  BMJ Case Rep       Date:  2014-08-12

4.  G6pd Deficiency Does Not Affect the Cytosolic Glutathione or Thioredoxin Antioxidant Defense in Mouse Cochlea.

Authors:  Karessa White; Mi-Jung Kim; Dalian Ding; Chul Han; Hyo-Jin Park; Zaimary Meneses; Masaru Tanokura; Paul Linser; Richard Salvi; Shinichi Someya
Journal:  J Neurosci       Date:  2017-05-04       Impact factor: 6.167

5.  Coupling between Protein Stability and Catalytic Activity Determines Pathogenicity of G6PD Variants.

Authors:  Anna D Cunningham; Alexandre Colavin; Kerwyn Casey Huang; Daria Mochly-Rosen
Journal:  Cell Rep       Date:  2017-03-14       Impact factor: 9.423

6.  CYP2C19 drug-drug and drug-gene interactions in ED patients.

Authors:  Hanna K Flaten; Howard S Kim; Jenny Campbell; Lisa Hamilton; Andrew A Monte
Journal:  Am J Emerg Med       Date:  2015-11-09       Impact factor: 2.469

7.  Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice.

Authors:  Andrew A Monte; Vasilis Vasiliou; Kennon J Heard
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2012-03-16

8.  G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic.

Authors:  Julia Z Xu; Richard O Francis; Leonel E Lerebours Nadal; Maryam Shirazi; Vaidehi Jobanputra; Eldad A Hod; Jeffrey S Jhang; Brie A Stotler; Steven L Spitalnik; Stephen W Nicholas
Journal:  Am J Trop Med Hyg       Date:  2015-08-03       Impact factor: 2.345

9.  Cloning, expression, purification and characterization of his-tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield.

Authors:  Saúl Gómez-Manzo; Jessica Terrón-Hernández; Ignacio de la Mora-de la Mora; Itzhel García-Torres; Gabriel López-Velázquez; Horacio Reyes-Vivas; Jesús Oria-Hernández
Journal:  Protein J       Date:  2013-10       Impact factor: 2.371

10.  Impact of the method of G6PD deficiency assessment on genetic association studies of malaria susceptibility.

Authors:  Marla K Johnson; Tamara D Clark; Denise Njama-Meya; Philip J Rosenthal; Sunil Parikh
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.